Obtaining Drugs For Research Use

Instructions for obtaining a DEA license for controlled substances

If using Schedule II-V drugs, follow these instructions:

Apply for the MD Controlled Dangerous Substances (CDS) registration at Maryland CDS Application. For Schedule II-V, you must do this before applying for the Federal DEA license. On the OCSA homepage, select “Practitioner- 3 year application.”

• Once on the form, select Researcher Schedule II, III, IV, V depending on which drugs you will be using (Section 1A). The schedules for commonly used drugs can be found at DEA Drug Scheduling.
• Provide a physical address where the drugs will be used, including building and laboratory room number (Section 2C).
• For “Professional License #,” enter N/A if you do not have one (Section 3A).
• For “Federal DEA license #,” enter Pending (Section 3B).
• As a researcher, you will not prescribe drugs, so you do not need to register with the PDMP. Write N/A (Sections 4 & 5).
• Save as a PDF when complete.

You will also need to fill out the Researcher Questionnaire.

• For the questions on the form concerning storage, inventory, and disposal of controlled drugs, please refer to the ACUC website: Storage and Record Keeping of Controlled Drugs.
• For the reverse distributor, JHU Department of Health and Environmental Safety will help facilitate disposal, but they are not a DEA-licensed reverse distributor. You must enter the information for the company they use if you intend to use this service. The required information is:Triumvirate EnvironmentalDEA license # RT0576198200 Inner Belt Rd, Somerville, MA 02143Phone: (866) 944-6983

Print out the application and Researcher Questionnaire and mail with payment of $120 (valid for 3 years) to the following address: OCSA, 4201 Patterson Avenue, 5th Floor, Baltimore, MD 21215.

Allow approximately 7-10 business days for the process to be completed, including mailing of permit. Application status can be checked at: OCSA Application Status. If OCSA verification web page states “pending,” contact OCSA for follow-up and clarification.

When the Maryland CDS registration is approved, apply for the federal DEA license. You will need your MD registration number to complete the form.

• Go to DEA Registration.
• Select “New Applications.”
• Under Business Category, select “Researcher” (Form 225), scroll down to Business Activity and select the appropriate Researcher category.
• Complete all sections, making sure the information matches what you entered for your MD application.
• Submit credit card payment of $296 along with the completed form.
• Federal DEA licenses must be renewed annually.

For Schedule I drugs, you must register with the Federal DEA first, then apply for the MD CDS registration.

If one has these licenses, then the next step is to set up your own account with MWI. Please contact [email protected] for the necessary forms and process, or call customer service at 1-800-824-3703 for more information.

A form for obtaining buprenorphine extended release (ER) can be filled out here. Please email to [email protected] upon completion.

Once you fill out this form and we fax your prescription, the person whose name was filled in on the form will need to call Wedgewood Pharmacy to set up an account, if you do not have an account already. Payment for the order must be submitted via credit card, as Wedgewood does not currently accept purchase orders. From this point forward, all information regarding this prescription will be obtained directly from Wedgewood, not from RAR.

If you request any refills on the original prescription, you can simply go to their website and use their refill page, or you may also call Wedgewood when you are ready to fill the order. Please note that the original prescription is only good for six (6) months, regardless of how many refills are on the original prescription. When there are no more refills, you will need to fill out the buprenorphine ER request form again to request a refill.

IMPORTANT: Buprenorphine ER cannot be diluted due to the specific formulation, and it expires (28) twenty-eight days after the first puncture. We encourage you and your lab members to read over the drug information sheet, as well as to visit Wedgewood’s website.

Please click here to download the JHU Animal Care and Use Committee’s current guidelines on record-keeping, storage, and disposal of drugs scheduled under the Controlled Substances Act (CSA).